English
简体中文
Total: £ 56.28
Published Date: 2026-02-05 | Pages: 160 | Tables: 142 | Medical Care
The global Stem Cells market was valued at US$ 3712 million in 2025 and is anticipated to reach US$ 7583 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Market Driver:
The Stem Cells market is driven by increasing research and development in regenerative medicine and the growing demand for innovative treatments for chronic diseases. Stem cell therapy has shown promising results in treating conditions such as neurodegenerative disorders, cardiovascular diseases, and orthopedic injuries. Additionally, advancements in biotechnology, such as induced pluripotent stem cells (iPSCs) and CRISPR-based gene editing, are expanding the potential applications of stem cells in personalized medicine. Government and private sector investments in stem cell research, along with regulatory approvals for new therapies, are further propelling market growth.
Market Challenge:
Despite its potential, the Stem Cells market faces challenges related to ethical concerns, regulatory complexities, and high costs. The use of embryonic stem cells remains controversial, leading to restrictions in certain regions. Additionally, stem cell therapies require stringent regulatory approvals due to safety concerns, including tumor formation and immune rejection risks. The high cost of stem cell treatments and the complexity of large-scale manufacturing also pose barriers to widespread adoption. Overcoming these challenges requires continued research, improved standardization, and policy support to ensure the safe and ethical development of stem cell therapies.
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
This report delivers a comprehensive overview of the global Stem Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cells. The Stem Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Stem Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stem Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
Segment by Type
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Segment by Application
Blood Disease
Cancer
Autoimmune Disease
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Stem Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Stem Cells Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cells Market Perspective (2021–2032)
2.2 Global Stem Cells Growth Trends by Region
2.2.1 Global Stem Cells Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Stem Cells Historic Market Size by Region (2021–2026)
2.2.3 Stem Cells Forecasted Market Size by Region (2027–2032)
2.3 Stem Cells Market Dynamics
2.3.1 Stem Cells Industry Trends
2.3.2 Stem Cells Market Drivers
2.3.3 Stem Cells Market Challenges
2.3.4 Stem Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cells Players by Revenue
3.1.1 Global Top Stem Cells Players by Revenue (2021–2026)
3.1.2 Global Stem Cells Revenue Market Share by Players (2021–2026)
3.2 Global Top Stem Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Stem Cells Revenue
3.4 Global Stem Cells Market Concentration Ratio
3.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2025
3.5 Global Key Players of Stem Cells Head Offices and Areas Served
3.6 Global Key Players of Stem Cells, Products and Applications
3.7 Global Key Players of Stem Cells, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Stem Cells Breakdown Data by Type
4.1 Global Stem Cells Historic Market Size by Type (2021–2026)
4.2 Global Stem Cells Forecasted Market Size by Type (2027–2032)
5 Stem Cells Breakdown Data by Application
5.1 Global Stem Cells Historic Market Size by Application (2021–2026)
5.2 Global Stem Cells Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Stem Cells Market Size (2021–2032)
6.2 North America Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Stem Cells Market Size by Country (2021–2026)
6.4 North America Stem Cells Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cells Market Size (2021–2032)
7.2 Europe Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Stem Cells Market Size by Country (2021–2026)
7.4 Europe Stem Cells Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cells Market Size (2021–2032)
8.2 Asia-Pacific Stem Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Stem Cells Market Size by Region (2021–2026)
8.4 Asia-Pacific Stem Cells Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cells Market Size (2021–2032)
9.2 Latin America Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Stem Cells Market Size by Country (2021–2026)
9.4 Latin America Stem Cells Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cells Market Size (2021–2032)
10.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Stem Cells Market Size by Country (2021–2026)
10.4 Middle East & Africa Stem Cells Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Osiris Therapeutics
11.1.1 Osiris Therapeutics Company Details
11.1.2 Osiris Therapeutics Business Overview
11.1.3 Osiris Therapeutics Stem Cells Introduction
11.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2021–2026)
11.1.5 Osiris Therapeutics Recent Development
11.2 NuVasive
11.2.1 NuVasive Company Details
11.2.2 NuVasive Business Overview
11.2.3 NuVasive Stem Cells Introduction
11.2.4 NuVasive Revenue in Stem Cells Business (2021–2026)
11.2.5 NuVasive Recent Development
11.3 Chiesi Pharmaceuticals
11.3.1 Chiesi Pharmaceuticals Company Details
11.3.2 Chiesi Pharmaceuticals Business Overview
11.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2021–2026)
11.3.5 Chiesi Pharmaceuticals Recent Development
11.4 Medi-post
11.4.1 Medi-post Company Details
11.4.2 Medi-post Business Overview
11.4.3 Medi-post Stem Cells Introduction
11.4.4 Medi-post Revenue in Stem Cells Business (2021–2026)
11.4.5 Medi-post Recent Development
11.5 JCR Pharmaceutical
11.5.1 JCR Pharmaceutical Company Details
11.5.2 JCR Pharmaceutical Business Overview
11.5.3 JCR Pharmaceutical Stem Cells Introduction
11.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2021–2026)
11.5.5 JCR Pharmaceutical Recent Development
11.6 MolMed
11.6.1 MolMed Company Details
11.6.2 MolMed Business Overview
11.6.3 MolMed Stem Cells Introduction
11.6.4 MolMed Revenue in Stem Cells Business (2021–2026)
11.6.5 MolMed Recent Development
11.7 Pharmicell
11.7.1 Pharmicell Company Details
11.7.2 Pharmicell Business Overview
11.7.3 Pharmicell Stem Cells Introduction
11.7.4 Pharmicell Revenue in Stem Cells Business (2021–2026)
11.7.5 Pharmicell Recent Development
11.8 Anterogen
11.8.1 Anterogen Company Details
11.8.2 Anterogen Business Overview
11.8.3 Anterogen Stem Cells Introduction
11.8.4 Anterogen Revenue in Stem Cells Business (2021–2026)
11.8.5 Anterogen Recent Development
11.9 Takeda (TiGenix)
11.9.1 Takeda (TiGenix) Company Details
11.9.2 Takeda (TiGenix) Business Overview
11.9.3 Takeda (TiGenix) Stem Cells Introduction
11.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2021–2026)
11.9.5 Takeda (TiGenix) Recent Development
11.10 CBR
11.10.1 CBR Company Details
11.10.2 CBR Business Overview
11.10.3 CBR Stem Cells Introduction
11.10.4 CBR Revenue in Stem Cells Business (2021–2026)
11.10.5 CBR Recent Development
11.11 ViaCord
11.11.1 ViaCord Company Details
11.11.2 ViaCord Business Overview
11.11.3 ViaCord Stem Cells Introduction
11.11.4 ViaCord Revenue in Stem Cells Business (2021–2026)
11.11.5 ViaCord Recent Development
11.12 Esperite
11.12.1 Esperite Company Details
11.12.2 Esperite Business Overview
11.12.3 Esperite Stem Cells Introduction
11.12.4 Esperite Revenue in Stem Cells Business (2021–2026)
11.12.5 Esperite Recent Development
11.13 LifeCell
11.13.1 LifeCell Company Details
11.13.2 LifeCell Business Overview
11.13.3 LifeCell Stem Cells Introduction
11.13.4 LifeCell Revenue in Stem Cells Business (2021–2026)
11.13.5 LifeCell Recent Development
11.14 CCBC
11.14.1 CCBC Company Details
11.14.2 CCBC Business Overview
11.14.3 CCBC Stem Cells Introduction
11.14.4 CCBC Revenue in Stem Cells Business (2021–2026)
11.14.5 CCBC Recent Development
11.15 VCANBIO
11.15.1 VCANBIO Company Details
11.15.2 VCANBIO Business Overview
11.15.3 VCANBIO Stem Cells Introduction
11.15.4 VCANBIO Revenue in Stem Cells Business (2021–2026)
11.15.5 VCANBIO Recent Development
11.16 BOYA LIFE
11.16.1 BOYA LIFE Company Details
11.16.2 BOYA LIFE Business Overview
11.16.3 BOYA LIFE Stem Cells Introduction
11.16.4 BOYA LIFE Revenue in Stem Cells Business (2021–2026)
11.16.5 BOYA LIFE Recent Development
11.17 Beike Biotechnology
11.17.1 Beike Biotechnology Company Details
11.17.2 Beike Biotechnology Business Overview
11.17.3 Beike Biotechnology Stem Cells Introduction
11.17.4 Beike Biotechnology Revenue in Stem Cells Business (2021–2026)
11.17.5 Beike Biotechnology Recent Development
11.18 International Medical
11.18.1 International Medical Company Details
11.18.2 International Medical Business Overview
11.18.3 International Medical Stem Cells Introduction
11.18.4 International Medical Revenue in Stem Cells Business (2021–2026)
11.18.5 International Medical Recent Development
11.19 Global Cord Blood Corporation
11.19.1 Global Cord Blood Corporation Company Details
11.19.2 Global Cord Blood Corporation Business Overview
11.19.3 Global Cord Blood Corporation Stem Cells Introduction
11.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2021–2026)
11.19.5 Global Cord Blood Corporation Recent Development
11.20 Beijing Health-Biotech Group
11.20.1 Beijing Health-Biotech Group Company Details
11.20.2 Beijing Health-Biotech Group Business Overview
11.20.3 Beijing Health-Biotech Group Stem Cells Introduction
11.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2021–2026)
11.20.5 Beijing Health-Biotech Group Recent Development
11.21 ABMD
11.21.1 ABMD Company Details
11.21.2 ABMD Business Overview
11.21.3 ABMD Stem Cells Introduction
11.21.4 ABMD Revenue in Stem Cells Business (2021–2026)
11.21.5 ABMD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Stem Cell Storage
Table 3. Key Players of Stem Cell Pharmaceutical and Treatment
Table 4. Global Stem Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Stem Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Stem Cells Market Size by Region (US$ Million), 2021–2026
Table 7. Global Stem Cells Market Share by Region (2021–2026)
Table 8. Global Stem Cells Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Stem Cells Market Share by Region (2027–2032)
Table 10. Stem Cells Market Trends
Table 11. Stem Cells Market Drivers
Table 12. Stem Cells Market Challenges
Table 13. Stem Cells Market Restraints
Table 14. Global Stem Cells Revenue by Players (US$ Million), 2021–2026
Table 15. Global Stem Cells Market Share by Players (2021–2026)
Table 16. Global Top Stem Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cells Revenue, 2025
Table 17. Ranking of Global Top Stem Cells Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Stem Cells Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Stem Cells, Headquarters and Area Served
Table 20. Global Key Players of Stem Cells, Products and Applications
Table 21. Global Key Players of Stem Cells, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Stem Cells Market Size by Type (US$ Million), 2021–2026
Table 24. Global Stem Cells Revenue Market Share by Type (2021–2026)
Table 25. Global Stem Cells Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Stem Cells Revenue Market Share by Type (2027–2032)
Table 27. Global Stem Cells Market Size by Application (US$ Million), 2021–2026
Table 28. Global Stem Cells Revenue Market Share by Application (2021–2026)
Table 29. Global Stem Cells Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Stem Cells Revenue Market Share by Application (2027–2032)
Table 31. North America Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 33. North America Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Stem Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Stem Cells Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Stem Cells Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Stem Cells Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Stem Cells Market Size by Country (US$ Million), 2027–2032
Table 46. Osiris Therapeutics Company Details
Table 47. Osiris Therapeutics Business Overview
Table 48. Osiris Therapeutics Stem Cells Product
Table 49. Osiris Therapeutics Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 50. Osiris Therapeutics Recent Development
Table 51. NuVasive Company Details
Table 52. NuVasive Business Overview
Table 53. NuVasive Stem Cells Product
Table 54. NuVasive Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 55. NuVasive Recent Development
Table 56. Chiesi Pharmaceuticals Company Details
Table 57. Chiesi Pharmaceuticals Business Overview
Table 58. Chiesi Pharmaceuticals Stem Cells Product
Table 59. Chiesi Pharmaceuticals Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 60. Chiesi Pharmaceuticals Recent Development
Table 61. Medi-post Company Details
Table 62. Medi-post Business Overview
Table 63. Medi-post Stem Cells Product
Table 64. Medi-post Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 65. Medi-post Recent Development
Table 66. JCR Pharmaceutical Company Details
Table 67. JCR Pharmaceutical Business Overview
Table 68. JCR Pharmaceutical Stem Cells Product
Table 69. JCR Pharmaceutical Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 70. JCR Pharmaceutical Recent Development
Table 71. MolMed Company Details
Table 72. MolMed Business Overview
Table 73. MolMed Stem Cells Product
Table 74. MolMed Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 75. MolMed Recent Development
Table 76. Pharmicell Company Details
Table 77. Pharmicell Business Overview
Table 78. Pharmicell Stem Cells Product
Table 79. Pharmicell Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 80. Pharmicell Recent Development
Table 81. Anterogen Company Details
Table 82. Anterogen Business Overview
Table 83. Anterogen Stem Cells Product
Table 84. Anterogen Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 85. Anterogen Recent Development
Table 86. Takeda (TiGenix) Company Details
Table 87. Takeda (TiGenix) Business Overview
Table 88. Takeda (TiGenix) Stem Cells Product
Table 89. Takeda (TiGenix) Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 90. Takeda (TiGenix) Recent Development
Table 91. CBR Company Details
Table 92. CBR Business Overview
Table 93. CBR Stem Cells Product
Table 94. CBR Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 95. CBR Recent Development
Table 96. ViaCord Company Details
Table 97. ViaCord Business Overview
Table 98. ViaCord Stem Cells Product
Table 99. ViaCord Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 100. ViaCord Recent Development
Table 101. Esperite Company Details
Table 102. Esperite Business Overview
Table 103. Esperite Stem Cells Product
Table 104. Esperite Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 105. Esperite Recent Development
Table 106. LifeCell Company Details
Table 107. LifeCell Business Overview
Table 108. LifeCell Stem Cells Product
Table 109. LifeCell Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 110. LifeCell Recent Development
Table 111. CCBC Company Details
Table 112. CCBC Business Overview
Table 113. CCBC Stem Cells Product
Table 114. CCBC Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 115. CCBC Recent Development
Table 116. VCANBIO Company Details
Table 117. VCANBIO Business Overview
Table 118. VCANBIO Stem Cells Product
Table 119. VCANBIO Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 120. VCANBIO Recent Development
Table 121. BOYA LIFE Company Details
Table 122. BOYA LIFE Business Overview
Table 123. BOYA LIFE Stem Cells Product
Table 124. BOYA LIFE Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 125. BOYA LIFE Recent Development
Table 126. Beike Biotechnology Company Details
Table 127. Beike Biotechnology Business Overview
Table 128. Beike Biotechnology Stem Cells Product
Table 129. Beike Biotechnology Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 130. Beike Biotechnology Recent Development
Table 131. International Medical Company Details
Table 132. International Medical Business Overview
Table 133. International Medical Stem Cells Product
Table 134. International Medical Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 135. International Medical Recent Development
Table 136. Global Cord Blood Corporation Company Details
Table 137. Global Cord Blood Corporation Business Overview
Table 138. Global Cord Blood Corporation Stem Cells Product
Table 139. Global Cord Blood Corporation Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 140. Global Cord Blood Corporation Recent Development
Table 141. Beijing Health-Biotech Group Company Details
Table 142. Beijing Health-Biotech Group Business Overview
Table 143. Beijing Health-Biotech Group Stem Cells Product
Table 144. Beijing Health-Biotech Group Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 145. Beijing Health-Biotech Group Recent Development
Table 146. ABMD Company Details
Table 147. ABMD Business Overview
Table 148. ABMD Stem Cells Product
Table 149. ABMD Revenue in Stem Cells Business (US$ Million), 2021–2026
Table 150. ABMD Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Stem Cells Picture
Figure 2. Global Stem Cells Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Stem Cells Market Share by Type: 2025 vs 2032
Figure 4. Stem Cell Storage Features
Figure 5. Stem Cell Pharmaceutical and Treatment Features
Figure 6. Global Stem Cells Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Stem Cells Market Share by Application: 2025 vs 2032
Figure 8. Blood Disease Case Studies
Figure 9. Cancer Case Studies
Figure 10. Autoimmune Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Stem Cells Report Years Considered
Figure 13. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Stem Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Stem Cells Market Share by Region: 2025 vs 2032
Figure 16. Global Stem Cells Market Share by Players in 2025
Figure 17. Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Stem Cells Revenue in 2025
Figure 19. North America Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Stem Cells Market Share by Country (2021–2032)
Figure 21. United States Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Stem Cells Market Share by Country (2021–2032)
Figure 25. Germany Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Stem Cells Market Share by Region (2021–2032)
Figure 33. China Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Stem Cells Market Share by Country (2021–2032)
Figure 41. Mexico Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Stem Cells Market Share by Country (2021–2032)
Figure 45. Israel Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Stem Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 49. NuVasive Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 50. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 51. Medi-post Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 52. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 53. MolMed Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 54. Pharmicell Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 55. Anterogen Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 56. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 57. CBR Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 58. ViaCord Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 59. Esperite Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 60. LifeCell Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 61. CCBC Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 62. VCANBIO Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 63. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 64. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 65. International Medical Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 66. Global Cord Blood Corporation Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 67. Beijing Health-Biotech Group Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 68. ABMD Revenue Growth Rate in Stem Cells Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
